|
Even after 5 years of adjuvant endocrine therapy, patients with HR positive tumors have a persistent risk of recurrence and death caused by breast cancer for at least 30 years after diagnosis, and this risk may be particularly high in young women <a href=http://propeci.buzz>finpecia uk</a> |
|